Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ND-12 Combined With H-6 in Adult Chronic Inflammatory Diarrhea
NCT07767370Phase 1Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Jul 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ND-12 and H-6 in Chronic inflammatory diarrhea and ulcerative colitis (UC) (3 arms), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoint: Fecal calprotectin level at 14 days. Started Jul 2026; status: recruiting.
02
Drugs
ND-12H-6
03
Conditions
Chronic inflammatory diarrheaulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07767370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07767370.